Actively Recruiting
Prevalence and Impact of Pertussis and RSV on Asthma Severity and Control
Led by Hospital Clinico Universitario de Santiago · Updated on 2024-03-01
784
Participants Needed
1
Research Sites
131 weeks
Total Duration
On this page
Sponsors
H
Hospital Clinico Universitario de Santiago
Lead Sponsor
T
Translational Research In Airway Diseases Group (TRIAD)
Collaborating Sponsor
AI-Summary
What this Trial Is About
The main objective is to estimate the annual symptomatic incidence of Bordetella pertussis and RSV infections in patients aged 18 years and over with asthma, which will be identified by PCR, for Bordetella pertussis and by PCR for RSV performed at a specific timepoint from onset of symptoms for each symptomatic Acute Respiratory Infection (ARI). A multicentre prospective cohort study will be undertaken in Spain. Thirty-five centres from different autonomous communities in Spain will participate in the study. Participants will be asked to report to the investigator if they experience an asthma exacerbation or symptoms of acute respiratory infection with 2 years follow up
CONDITIONS
Official Title
Prevalence and Impact of Pertussis and RSV on Asthma Severity and Control
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patient aged 18 years and over
- Diagnosed with asthma at least one year before enrolling
- Able and willing to follow study requirements and attend testing when symptoms occur
- Able to provide written informed consent
You will not qualify if you...
- History of pertussis infection within the last 12 months
- Acute respiratory infection within 2 weeks before enrollment
- Having other respiratory diseases besides asthma, alcohol or drug abuse, active cancer treatment or follow-up, or pregnancy
- Treated with immunosuppressive or immunomodulating drugs not related to asthma
- Vaccinated for RSV or received an investigational RSV vaccine or medicine prior to study
- Vaccinated for Bordetella pertussis within the previous 12 months
- Planning to move away during the study period
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hospital Clínico Universitario de Santiago de Compostela
Santiago de Compostela, A Coruña, Spain, 15706
Actively Recruiting
Research Team
F
Francisco-Javier GONZALEZ BARCALA, MD, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here